1. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects
   Mehrdad Hashemi et al, 2022, Life Sciences CrossRef
2. RNA binding proteins in cancer chemotherapeutic drug resistance
   Hemanathan Vembuli et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
3. (Nano)platforms in bladder cancer therapy: Challenges and opportunities
   Milad Ashrafizadeh et al, 2023, Bioengineering & Translational Medicine CrossRef
4. METTL5 promotes gastric cancer progression via sphingomyelin metabolism
   Ya-Qiong Zhang et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
5. Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy
   C. Mir et al, 2022, Seminars in Cancer Biology CrossRef
6. Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
   Zhoujun Lin et al, 2022, International Journal of Molecular Sciences CrossRef
7. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma
   Leizuo Zhao et al, 2023, Pathology - Research and Practice CrossRef
8. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
   Fei Li et al, 2023, Drug Resistance Updates CrossRef
9. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation
   Houqing Yin et al, 2023, European Journal of Pharmacology CrossRef
10. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma
    Yanzhao Jin et al, 2023, Journal of Chemotherapy CrossRef
11. Association between abnormal lipid metabolism and tumor
    Chunyu Li et al, 2023, Frontiers in Endocrinology CrossRef